SIROLIMUS

Generic: SIROLIMUS

Camber PharmaceuticalsManufacturer
ORALRoute
SIROLIMUSActive Substance
2024-09-16Original Approval

SIROLIMUS is FDA application ANDA215080, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
2,076 reports
2
DRUG INEFFECTIVE
1,139 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
786 reports
4
PYREXIA
531 reports
5
DIARRHOEA
529 reports
6
PNEUMONIA
500 reports
7
DRUG INTERACTION
450 reports
8
ACUTE KIDNEY INJURY
443 reports
9
THROMBOTIC MICROANGIOPATHY
386 reports
10
TRANSPLANT REJECTION
384 reports